Article

Switching From IV to Oral Meds Cuts Healthcare Costs

Switching clinically eligible patients from IV to oral medications can lower the yearly cost of healthcare, according to a recent study published online in Clinical Therapeutics.

Researchers from the Johns Hopkins University School of Medicine in Baltimore reviewed four costly medications and determined that the potential impact on hospital savings could be substantial.

Further details and the abstract are available at: http://www.mdnews.com/news/hd/2011_45/hd_658375

Sources: Clinical Therapeutics, HealthDay, MD News

Related Videos
Chelsee Jensen, PharmD, BCPS.
Jonathan Eisengart, MD
Sarah Anderson, oncology strategy lead director, Novotech
5 experts are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo